heart attack, stroke, death from heart disease) in adults with type 2 diabetes The Wegovy pill is approved to: Reduce excess body weight and maintain weight reduction long term in Adults with obesity Adults with overweight and at least one weight-related medical condition (e.g
Primary function: Reconstitution and dilution of powdered or concentrated drug products before parenteral (IV, IM, or SC) administration, not for direct IV infusion alone
1,5,6 None have been definitively established
Ongoing clinical trials and strong pharmaceutical investments are accelerating adoption and market expansion
Past research shows that people with type 2 diabetes have an increased risk for developing Alzheimers disease
Colorectal cancer progression occurred in 13% of GLP-1 users versus 22% of DPP-4 inhibitor users, while liver cancer progression occurred in 19% versus 28%